Extended RAS Testing Urged Before EGFR MoAB Therapy
Extended testing recommended for mutations in KRAS, NRAS in patients with metastatic CRC
Most Cancer Patients Believe Surgery Will Be Curative
Findings even among patients with stage IV lung, colorectal cancer
Early Detection Still Key to Breast Cancer Survival
Despite advances in treatment, finding smaller tumors linked to better results
Safety Concerns Raised for Antioxidant Use in Melanoma
Mouse study highlights link between N-acetylcysteine and melanoma progression
Young Cancer Survivors May Need Lifelong Screenings
Patients successfully treated at age 15 to 39 nearly 60 percent more likely to develop another cancer
Prognostic Disclosure Improves Life Expectancy Estimates
Prognostic disclosure linked to more realistic patient expectations in advanced cancer
FDA Approves Optune Device for Newly Diagnosed Glioblastoma
Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide
Ovarian Tissue Transplant Can Up Fertility Post Cancer Tx
Researchers in Denmark report a success rate of about 30 percent
Guidelines Developed for Managing Conflicts of Interest
Core principles developed for managing COIs during the clinical practice guideline development process
USPSTF Recommends CRC Screening for 50- to 75-Year-Olds
Grade A recommendation for 50- to 75-year-olds; individualized decision urged for those age 76 to 85
